title: Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool.
authors.affiliation: Laboratoire de Biochimie, Hôpital Debrousse, Lyon, France.
authors.forename: C
authors.initials: C
authors.lastname: Bory
authors.forename: R
authors.initials: R
authors.lastname: Boulieu
authors.forename: G
authors.initials: G
authors.lastname: Souillet
authors.forename: C
authors.initials: C
authors.lastname: Chantin
authors.forename: P
authors.initials: P
authors.lastname: Guibaud
authors.forename: M S
authors.initials: MS
authors.lastname: Hershfield
mesh_terms: D000243:Adenosine Deaminase / Q000172:deficiency* / Q000627:therapeutic use*; D000255:Adenosine Triphosphate / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006801:Humans; D007223:Infant; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008297:Male; D016511:Severe Combined Immunodeficiency / Q000097:blood / Q000188:drug therapy* / Q000276:immunology
chemical_list: D015415:Biomarkers; D000255:Adenosine Triphosphate; D000243:Adenosine Deaminase; C051409:pegademase bovine